Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity c-reactive protein in systemic lupus erythematosus

Rheumatology (United Kingdom)

Volumn 52, Issue 11, 2013, Pages 2071-2076

  Kiani, Adnan N ^a   Fang, Hong ^a   Magder, Laurence S ^b   Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Atherosclerosis; Systemic lupus erythematosus; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM;

ADULT; AFRICAN AMERICAN; ANALYTICAL PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CORONARY ARTERY; CORONARY ARTERY CALCIUM; CORONARY ARTERY CALCIUM SCORE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN D DEFICIENCY;

ATHEROSCLEROSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN D;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCIUM; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; VASCULAR CALCIFICATION; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84886312526     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket271     Document Type: Article

References (44)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266-81.
2. Lee JH, O'Keefe JH, Bell D et al. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008;52:1949-56.
3. Giovannucci E, Liu Y, Hollis BW, et al. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008;168:1174-80.
4. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004-13.
5. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
6. Giovannucci E, Liu Y, Hollis BW, et al. A prospective study of 25-hydroxyvitamin D in relation to risk of myocardial infarction in men. Arch Intern Med 2008;168:1174-80.
7. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9.
8. Nibbelink KA, Tishkoff DX, Hershey SD, et al. 1,25(OH)2- vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007;103:533-7.
9. Rahman A, Hershey S, Ahmed S, et al. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2007;103: 416-9.
10. Larsson P, Mattsson L, Klareskog L, et al. A vitamin D analogue (MC1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcemia. Clin Exp Immunol 1998;114: 277-83.
11. Cantorna MT, Munsick C, Bemiss C, et al. 1,25 Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000;130:2648-52.
12. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 2002;8:174-9.
13. Bultink IE, Lems WF, Kostense PJ. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:2044-50.
14. Kamen DL, Cooper GS, Bouali H. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5: 114-7.
15. Littorin B, Blom P, Scholin A. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006;49:2847-52.
16. Merlino LA, Curtis J, Mikuls TR. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004;50: 72-7.
17. Nieves J, Cosman F, Herbert J. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994;44:1687-92.
18. Wu PW, Rhew EY, Dyer AR. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Care Res 2009;61:1387-95.
19. Ravenell RL, Kamen DL, Spence JD, et al. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci 2012;344:268-73.
20. Reynolds JA, Haque S, Berry JL, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology 2012;51:544-51.
21. Mok CC, Birmingham DJ, Leung HW. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology 2012;51:644-52.
22. Kiani AN, Magder LS, Petri M. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors but not with disease activity. J Rheumatol 2008;35:1300-6.
23. Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter disease: a multicenter study. Circulation 1996;93:898-904.
24. Kopp AF, Ohnesorge B, Becker C, et al. Reproducibility and accuracy of coronary calcium measurements with multi-detector row versus electron-beam CT. Radiology 2002;225:113-9.
25. Bots ML, Mulder PG, Hofman A. Reproducibility of carotid vessel wall thickness measurements: the Rotterdam study. J Clin Epidemiol 1994;47:921-30.
26. Smilde TJ, Wollersheim H, Van Langen H. Reproducibility of ultrasonographic measurements of different carotid and femoral artery segments in healthy subjects and in patients with increased intima-media thickness. Clin Sci (Lond) 1997;93:317-24.
27. Doherty TM, Tang W, Dascalos S, et al. Ethnic origin and serum levels of 1a,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 1997; 96:1477-81.
28. Reis JP, von Muhlen D, Michos ED, et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 2009;207:589-90.
29. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755-60.
30. Freedman BI, Wageknecht LE, Hairston KG, et al. Vitamin D, adiposity and calcified atherosclerotic plaque inAfrican-Americans. J Clin Endocrinol Metab 2010;95: 1076-83.
31. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
32. Bassuk SS, Rifai N, Ridker PM. High sensitivity C reactive protein: clinical importance. Curr Probl Cardiol 2004;29: 439-93.
33. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
34. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous national health and nutrition examination survey 2001-2006). Am J Cardiol 2012;109:226-30.
35. Lee SS, Singh S, Magder LS, et al. Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 2008;17:114-23.
36. Mochizuki T, Aotsuka S, Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med 1999;93:95-101.
37. Moutsopoulos HM, Mavridis AK, Acritidis NC, et al. High Creactive protein response in lupus polyarthritis. Clin Exp Rheumatol 1983;1:53-5.
38. Liou LB. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol 2001;19:515-23.
39. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004;50:151-9.
40. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349: 2399-406.
41. Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary- artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407-15.
42. Svenungsson E, Jensen-Urstad K, Heimburger M, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001;104:1887-93.
43. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60.
44. Toloza SM, Uribe AG, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004;50:3947-57.